Healthcare2 min reading time

Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Ars Technica
Read full post
Moderna's mRNA flu vaccine, mFLUSIVA, has received FDA approval, marking a milestone for mRNA technology in flu prevention. The vaccine offers faster production and potential benefits over traditional flu shots but faces uncertainty due to a stalled CDC advisory panel and unclear insurance coverage.

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources
Healthcare6 min read

NYU-DRP AI Model Predicts Five-Year Breast Cancer Risk From 3D Mammograms

Unite.AI
Healthcare3 min read

Google’s map of every possible DNA typo could speed up rare disease research

Covered by 3 sources